Cidara and Melinta Win FDA Approval for First New Echinocandin in a Decade

Wednesday, the FDA approved Cidara Therapeutics and Melinta Therapeutics’ Rezzayo (rezafungin) injection to treat candidemia and invasive candidiasis.